Response to the Health Select Committee's recommendations on the future of the National Institute for Health and Clinical Excellence (NICE).
In this publication, the government confirms that the National Institute for Health and Clinical Excellence (NICE) will:
- play an important part in the future value-based pricing of branded medicines
- have a bigger role in evaluating drugs, through assessing a medicine’s benefits and costs
This will help make sure that the price the NHS pays for new medicines is more closely linked to their value to NHS patients and society.